https://www.selleckchem.com/pr....oducts/elacridar-gf1
The current study that has a currently population comprising 176 study participants aims to discover novel holistic entry points for achieving a better understanding of the poorly understood plasticity of involved molecular pathways and to define biomarkers enabling improved diagnostics and therapeutics. With this study description, we want to present the study design, population, and few ongoing experiments for novel biomarker research. Clinical Trial Registration German Clinical Trials Register (Deutsches Register für Klini
Like
Comment
Share
